Total Payments
$7,970
2024 Payments
$1,256
Companies
27
Transactions
668
Medicare Patients
6,172
Medicare Billing
$507,197
Payment Breakdown by Category
Food & Beverage$7,965 (99.9%)
Education$4.90 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,965 | 667 | 99.9% |
| Education | $4.90 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $942.35 | 73 | $0 (2024) |
| PFIZER INC. | $885.22 | 79 | $0 (2024) |
| Lilly USA, LLC | $798.97 | 52 | $0 (2024) |
| Novo Nordisk Inc | $797.88 | 52 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $657.51 | 58 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $622.94 | 14 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $603.00 | 81 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $513.61 | 104 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $379.00 | 31 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $353.03 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,256 | 79 | Lilly USA, LLC ($222.83) |
| 2023 | $1,333 | 92 | Lilly USA, LLC ($333.26) |
| 2022 | $508.85 | 30 | Biohaven Pharmaceutical Holding Company Ltd. ($98.93) |
| 2021 | $27.70 | 2 | Janssen Pharmaceuticals, Inc ($14.10) |
| 2020 | $166.66 | 11 | Novo Nordisk Inc ($74.86) |
| 2019 | $1,503 | 142 | Novo Nordisk Inc ($333.39) |
| 2018 | $1,586 | 152 | AstraZeneca Pharmaceuticals LP ($215.08) |
| 2017 | $1,587 | 160 | Merck Sharp & Dohme Corporation ($219.46) |
All Payment Transactions
668 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $10.01 | General |
| Category: Bone Health | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.31 | General |
| Category: Cardiovascular | ||||||
| 12/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Biological | ||||||
| 11/27/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $13.85 | General |
| 11/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.65 | General |
| Category: Cardiovascular | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $27.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/18/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $5.87 | General |
| Category: Bone Health | ||||||
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.50 | General |
| Category: Cardiovascular | ||||||
| 10/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Biological | ||||||
| 10/03/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Inflammation | ||||||
| 09/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Oncology | ||||||
| 09/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: DIABETES | ||||||
| 09/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: VACCINES | ||||||
| 09/05/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.08 | General |
| Category: Cardiovascular | ||||||
| 09/04/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Bone Health | ||||||
| 09/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Biological | ||||||
| 08/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,553 | 1,943 | $221,022 | $137,641 |
| 2022 | 17 | 1,503 | 1,895 | $211,097 | $133,718 |
| 2021 | 18 | 1,482 | 1,890 | $199,917 | $123,018 |
| 2020 | 16 | 1,634 | 2,064 | $191,401 | $112,820 |
Total Patients
6,172
Total Services
7,792
Medicare Billing
$507,197
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 325 | 442 | $77,628 | $40,920 | 52.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2023 | 283 | 283 | $36,094 | $35,372 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 258 | 424 | $53,175 | $27,120 | 51.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 226 | 231 | $15,535 | $11,053 | 71.2% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Facility | 2023 | 42 | 62 | $6,324 | $4,678 | 74.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 88 | 108 | $9,575 | $4,550 | 47.5% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 18 | 19 | $3,374 | $2,506 | 74.3% |
| 99496 | Transitional care management services for problem of high complexity | Facility | 2023 | 16 | 16 | $4,365 | $2,180 | 49.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Facility | 2023 | 11 | 44 | $2,692 | $1,670 | 62.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 23 | $2,039 | $1,460 | 71.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 20 | $2,654 | $1,415 | 53.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 14 | 14 | $2,274 | $1,046 | 46.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Facility | 2023 | 17 | 19 | $981.54 | $769.50 | 78.4% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Facility | 2023 | 11 | 17 | $918.68 | $599.18 | 65.2% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Facility | 2023 | 16 | 23 | $775.10 | $581.24 | 75.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 85 | 97 | $1,197 | $565.11 | 47.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 30 | 30 | $623.70 | $472.70 | 75.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Facility | 2023 | 41 | 41 | $385.84 | $372.28 | 96.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 30 | 30 | $410.40 | $310.88 | 75.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 328 | 402 | $71,685 | $38,607 | 53.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2022 | 287 | 287 | $37,331 | $36,837 | 98.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 241 | 420 | $53,570 | $28,666 | 53.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 169 | 233 | $20,923 | $10,542 | 50.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 171 | 174 | $12,029 | $8,337 | 69.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 35 | $3,282 | $2,238 | 68.2% |
About Dr. Robert Allison, MD
Dr. Robert Allison, MD is a Internal Medicine healthcare provider based in Pierre, South Dakota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154393742.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Allison, MD has received a total of $7,970 in payments from pharmaceutical and medical device companies, with $1,256 received in 2024. These payments were reported across 668 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($7,965).
As a Medicare-enrolled provider, Allison has provided services to 6,172 Medicare beneficiaries, totaling 7,792 services with total Medicare billing of $507,197. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Pierre, SD
- Active Since 02/07/2006
- Last Updated 04/04/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1154393742
Products in Payments
- FARXIGA (Drug) $510.82
- MOUNJARO (Drug) $418.84
- JANUVIA (Drug) $408.19
- EVENITY (Biological) $403.56
- JARDIANCE (Drug) $396.13
- Ozempic (Drug) $370.71
- XARELTO (Drug) $368.55
- ENTRESTO (Drug) $287.28
- ELIQUIS (Drug) $274.60
- Prolia (Biological) $265.71
- NURTEC ODT (Drug) $246.84
- CHANTIX (Drug) $241.26
- INJECTAFER (Drug) $216.04
- Tresiba (Drug) $175.64
- Victoza (Drug) $163.49
- INVOKANA (Drug) $145.06
- Veozah (Drug) $135.13
- TRULICITY (Drug) $132.10
- TRELEGY ELLIPTA (Drug) $129.31
- Otezla (Drug) $126.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.